Transform Wealth, LLC Amgen Inc Transaction History

Transform Wealth, LLC

  • $1.46 Billion
  • Q3 2024

A detailed history of Transform Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Transform Wealth, LLC holds 1,223 shares of AMGN stock, worth $360,210. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,223
Previous 1,220 0.25%
Holding current value
$360,210
Previous $381,000 3.41%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$309.38 - $337.38 $928 - $1,012
3 Added 0.25%
1,223 $394,000
Q2 2024

Jul 15, 2024
SELL
$262.75 - $319.31 $12,349 - $15,007
-47 Reduced 3.71%
1,220 $381,000
Q1 2024

Apr 15, 2024
SELL
$268.87 - $324.56 $1,613 - $1,947
-6 Reduced 0.47%
1,267 $360,000
Q4 2023

Jan 18, 2024
SELL
$255.7 - $288.46 $4,346 - $4,903
-17 Reduced 1.32%
1,273 $366,000
Q3 2023

Oct 10, 2023
SELL
$218.65 - $271.46 $13,337 - $16,559
-61 Reduced 4.52%
1,290 $346,000
Q2 2023

Jul 13, 2023
BUY
$214.27 - $253.37 $46,068 - $54,474
215 Added 18.93%
1,351 $299,000
Q1 2023

Apr 14, 2023
SELL
$225.79 - $275.2 $38,835 - $47,334
-172 Reduced 13.15%
1,136 $274,000
Q4 2022

Jan 12, 2023
SELL
$229.03 - $291.01 $15,574 - $19,788
-68 Reduced 4.94%
1,308 $0
Q3 2022

Oct 21, 2022
SELL
$224.46 - $253.15 $248,701 - $280,490
-1,108 Reduced 44.61%
1,376 $310,000
Q2 2022

Jul 15, 2022
SELL
$230.71 - $256.74 $9,228 - $10,269
-40 Reduced 1.58%
2,484 $604,000
Q1 2022

Apr 25, 2022
BUY
$219.27 - $242.57 $246,020 - $272,163
1,122 Added 80.03%
2,524 $611,000
Q4 2021

Jan 26, 2022
SELL
$198.88 - $227.6 $313,236 - $358,470
-1,575 Reduced 52.91%
1,402 $315,000
Q3 2021

Oct 15, 2021
SELL
$212.27 - $248.7 $5.8 Million - $6.8 Million
-27,345 Reduced 90.18%
2,977 $633,000
Q2 2021

Jul 20, 2021
BUY
$233.58 - $259.14 $3.9 Million - $4.33 Million
16,693 Added 122.48%
30,322 $7.39 Million
Q1 2021

Apr 22, 2021
SELL
$221.91 - $258.6 $112,730 - $131,368
-508 Reduced 3.59%
13,629 $3.39 Million
Q4 2020

Jan 20, 2021
SELL
$216.38 - $257.67 $2.85 Million - $3.4 Million
-13,176 Reduced 48.24%
14,137 $3.25 Million
Q3 2020

Oct 21, 2020
SELL
$234.65 - $260.95 $38,013 - $42,273
-162 Reduced 0.59%
27,313 $6.94 Million
Q2 2020

Jul 22, 2020
BUY
$197.81 - $242.74 $138,862 - $170,403
702 Added 2.62%
27,475 $6.48 Million
Q1 2020

Apr 30, 2020
BUY
$182.24 - $241.7 $157,273 - $208,587
863 Added 3.33%
26,773 $5.43 Million
Q4 2019

Jan 24, 2020
BUY
$189.21 - $243.2 $20,434 - $26,265
108 Added 0.42%
25,910 $6.25 Million
Q3 2019

Oct 24, 2019
SELL
$174.11 - $208.62 $91,407 - $109,525
-525 Reduced 1.99%
25,802 $4.99 Million
Q2 2019

Jul 30, 2019
SELL
$166.7 - $195.41 $703,640 - $824,825
-4,221 Reduced 13.82%
26,327 $4.85 Million
Q1 2019

Apr 12, 2019
SELL
$180.87 - $203.88 $264,974 - $298,684
-1,465 Reduced 4.58%
30,548 $5.8 Million
Q4 2018

Jan 30, 2019
BUY
$178.4 - $208.25 $310,237 - $362,146
1,739 Added 5.74%
32,013 $6.23 Million
Q3 2018

Oct 25, 2018
BUY
$185.29 - $208.89 $1.14 Million - $1.29 Million
6,159 Added 25.54%
30,274 $6.28 Million
Q2 2018

Aug 03, 2018
BUY
$166.05 - $186.51 $755,693 - $848,807
4,551 Added 23.26%
24,115 $4.45 Million
Q1 2018

May 03, 2018
BUY
$169.43 - $198.0 $121,820 - $142,362
719 Added 3.82%
19,564 $3.34 Million
Q4 2017

Feb 08, 2018
BUY
$168.79 - $188.59 $114,608 - $128,052
679 Added 3.74%
18,845 $3.28 Million
Q3 2017

Oct 19, 2017
BUY
$167.29 - $191.0 $3.04 Million - $3.47 Million
18,166
18,166 $3.39 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Transform Wealth, LLC Portfolio

Follow Transform Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email